Max Zinter

448 total citations
6 papers, 268 citations indexed

About

Max Zinter is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Max Zinter has authored 6 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Max Zinter's work include RNA Interference and Gene Delivery (2 papers), MicroRNA in disease regulation (2 papers) and Tuberous Sclerosis Complex Research (1 paper). Max Zinter is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), MicroRNA in disease regulation (2 papers) and Tuberous Sclerosis Complex Research (1 paper). Max Zinter collaborates with scholars based in United States, Malaysia and Brazil. Max Zinter's co-authors include Bakhos A. Tannous, Litia Carvalho, Ralph Weissleder, Hasan Akbaba, E. Antonio Chiocca, Tian Tian, Ayşe Gülten Kantarcı, Gülşah Erel‐Akbaba, Pierre J. Obeid and Ricardo Augusto de Melo Reis and has published in prestigious journals such as ACS Nano, JNCI Journal of the National Cancer Institute and Cell Reports.

In The Last Decade

Max Zinter

6 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Zinter United States	5	142	107	84	48	38	6	268
Rongjun Qian China	10	260 1.8×	109 1.0×	105 1.3×	74 1.5×	19 0.5×	22	408
G. Praveen Raju United States	9	273 1.9×	64 0.6×	59 0.7×	34 0.7×	35 0.9×	13	414
Łukasz Bożycki Poland	11	198 1.4×	66 0.6×	55 0.7×	40 0.8×	17 0.4×	20	374
Anton Wohl Israel	8	145 1.0×	55 0.5×	62 0.7×	38 0.8×	24 0.6×	14	304
Daniel Pomeranz Krummel United States	10	225 1.6×	84 0.8×	31 0.4×	31 0.6×	18 0.5×	21	383
Aleksandra V. Meleshina Russia	10	108 0.8×	112 1.0×	28 0.3×	30 0.6×	28 0.7×	16	322
Amanda Maffa United States	2	221 1.6×	146 1.4×	140 1.7×	19 0.4×	40 1.1×	2	383
Grazia Marsico Ireland	6	149 1.0×	55 0.5×	43 0.5×	26 0.5×	33 0.9×	9	264
Edgar González-Buendía Mexico	8	336 2.4×	84 0.8×	38 0.5×	107 2.2×	27 0.7×	12	454

Countries citing papers authored by Max Zinter

Since Specialization

Citations

This map shows the geographic impact of Max Zinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Zinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Zinter more than expected).

Fields of papers citing papers by Max Zinter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Zinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Zinter. The network helps show where Max Zinter may publish in the future.

Co-authorship network of co-authors of Max Zinter

This figure shows the co-authorship network connecting the top 25 collaborators of Max Zinter. A scholar is included among the top collaborators of Max Zinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Zinter. Max Zinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Schweiger, Markus, Tianhe Xiao, Max Zinter, et al.. (2024). Arming AAV9 with a Single-Chain Fragment Variable Antibody Against PD-1 for Systemic Glioblastoma Therapy. Molecular Neurobiology. 62(2). 2617–2625. 1 indexed citations

2.

Prabhakar, Shilpa, Pike-See Cheah, Max Zinter, et al.. (2019). Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Molecular Therapy — Methods & Clinical Development. 15. 18–26. 19 indexed citations

3.

Zaborowski, Mikołaj Piotr, Kyungheon Lee, Alessandro Sammarco, et al.. (2019). Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles. Cell Reports. 27(1). 255–268.e6. 34 indexed citations

4.

Hora, Cintia Carla da, Litia Carvalho, Max Zinter, et al.. (2019). Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition. Cell Death Discovery. 5(1). 72–72. 21 indexed citations

5.

Erel‐Akbaba, Gülşah, Litia Carvalho, Tian Tian, et al.. (2019). Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy. ACS Nano. 13(4). 4028–4040. 173 indexed citations

6.

Carvalho, Litia, et al.. (2018). Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy. JNCI Journal of the National Cancer Institute. 111(3). 283–291. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact